Company / Assets per Share
AVADEL PHARMACEUTICALS PLC Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.73
FY2024
5-year range
$1.73 / $5.67
FY2020-FY2024
Trend
-16.0%
vs FY2023
Sector context
#193 of 210
Health Care
What the data says
Among 210 Health Care companies, AVADEL PHARMACEUTICALS PLC is in the bottom 8% for assets per share. Assets per Share has declined for 4 consecutive years, from $5.67 in FY2020 to $1.73 in FY2024.
Based on SEC 10-K filings.
1.73 in FY2024 with a 5-year CAGR of -15.7%.
Declined from $2.21 to $1.73 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -25.8%
- 5-Year CAGR
- -15.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 210This company $1.73 Sector average $353.15
▼
-99.5% below sector average
Key checks
Key Insights
- AVADEL PHARMACEUTICALS PLC's assets per share has declined for 4 consecutive years.
- In FY2024, assets per share decreased 16.0% year-over-year.
- Ranks #193 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.73 | -16.0% |
| FY2023 | $2.05 | -7.0% |
| FY2022 | $2.21 | -47.7% |
| FY2021 | $4.22 | -25.5% |
| FY2020 | $5.67 | +40.1% |
| FY2019 | $4.05 | -20.6% |
| FY2018 | $5.10 | -15.9% |
| FY2017 | $6.06 | +1.9% |
| FY2016 | $5.95 | +20.7% |
| FY2015 | $4.93 | +2.5% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026